Olema Pharmaceuticals, Inc.

NasdaqGS:OLMA Stock Report

Market Cap: US$549.6m

Olema Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:OLMA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Dec 23BuyUS$1,160,000Paradigm Biocapital Advisors LPCompany100,000US$11.60
05 Dec 23BuyUS$1,871,280Logos Global Management, L.P.Company131,870US$14.95
22 Nov 23SellUS$269,656Shane William KovacsIndividual18,742US$15.27
22 Nov 23SellUS$824,134Sean BohenIndividual57,225US$15.29
22 Nov 23SellUS$117,740Cyrus HarmonIndividual8,181US$14.86
22 Nov 23SellUS$196,233David MylesIndividual13,629US$15.32
22 Nov 23SellUS$209,296Naseem ZojwallaIndividual14,556US$15.33
12 Sep 23BuyUS$4,999,999Logos Global Management, L.P.Company508,130US$9.84
12 Sep 23BuyUS$4,999,999Logos Global Management, L.P.Company508,130US$9.84
12 Sep 23BuyUS$14,818,371BVF Partners L.P.Company1,505,932US$9.84
08 Jun 23SellUS$63,000Cyrus HarmonIndividual10,000US$6.30
06 Jun 23SellUS$61,700Cyrus HarmonIndividual10,000US$6.30

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of OLMA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,5220.0187%
Individual Insiders2,969,7605.29%
VC/PE Firms3,040,2485.41%
Hedge Funds21,423,36838.2%
Institutions28,709,86551.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 37.6%.


Top Shareholders

Top 25 shareholders own 86.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.3%
BVF Partners L.P.
9,135,893US$89.8m0%2.26%
14.1%
Paradigm Biocapital Advisors LP
7,903,600US$77.7m1.28%3.95%
7.84%
Logos Global Management, L.P.
4,383,875US$43.1m17.1%5.42%
5.84%
BlackRock, Inc.
3,263,907US$32.1m45.5%no data
5.44%
Deep Track Capital, LP
3,040,248US$29.9m57.5%1.05%
4.84%
The Vanguard Group, Inc.
2,705,895US$26.6m58.2%no data
4.39%
Cormorant Asset Management, LP
2,456,800US$24.2m-45.5%1.36%
3.35%
Vivo Capital, LLC
1,873,704US$18.4m0%1.52%
3.32%
BioImpact Capital LLC
1,857,136US$18.3m-0.03%4.17%
3.07%
Dimensional Fund Advisors LP
1,715,420US$16.9m1.26%no data
1.7%
Cyrus Harmon
948,311US$9.3m-7.33%no data
1.48%
Geode Capital Management, LLC
824,833US$8.1m25.8%no data
1.34%
Woodline Partners LP
750,279US$7.4m4.59%0.08%
1.34%
Polar Capital Holdings Plc
750,000US$7.4m0%0.03%
1.33%
David Myles
741,776US$7.3m0.28%no data
1.25%
Janus Henderson Group plc
700,100US$6.9m0%no data
1.2%
State Street Global Advisors, Inc.
673,170US$6.6m20.4%no data
1.18%
Ally Bridge Group
659,035US$6.5m0%2.38%
1.13%
First Light Asset Management, LLC
631,064US$6.2m0%0.58%
1.11%
Victory Capital Management Inc.
621,527US$6.1m880%0.01%
1.03%
Silverarc Capital Management, LLC
573,830US$5.6m40.7%1.72%
0.97%
Perceptive Advisors LLC
539,831US$5.3m0%0.12%
0.89%
Adage Capital Management, L.P.
500,000US$4.9m28.5%0.01%
0.87%
Shane William Kovacs
484,987US$4.8m11.5%no data
0.74%
Altium Capital Management LP
413,607US$4.1m23.5%2.33%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.